Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toward the optimized assessment of clinical outcomes in studies of novel treatments for Alzheimer’s disease

Published:2022-10-03 Issue:10 Volume:22 Page:863-873
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Lipton Richard B¹,Podger Lauren²,Stewart Walter F³,Gomez-Ulloa David⁴^ORCID,Rodriguez Wilton I⁵,Runken M Chris⁵,Barnes Frederick B⁶,Serrano Daniel⁶

Affiliation:

1. The Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA

2. Patient Centered Outcomes, OPEN Health, London, UK

3. Medcurio Inc, Oakland, CA, USA

4. Global HEOR, Grifols - Sant Cugat Del Vallès, Barcelona, Spain

5. Global HEOR, Grifols SSNA - Research Triangle Park, NC, USA

6. Patient Centered Outcomes, OPEN Health, MD, USA

Funder

The development of this manuscript was sponsored by Grifols SSNA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2022.2149324

Reference121 articles.

1. 2019 Alzheimer's disease facts and figures

2. Alzheimer's disease

3. Neuropathological stageing of Alzheimer-related changes

4. Food and Drug Administration. Incorporating clinical outcome assessments into endpoints for regulatory decision making. 2018 https://www.fda.gov/media/132505/download.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP